Zelira Therapeutics (AU:ZLD) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Zelira Therapeutics Limited has announced the issuance of 3.5 million unquoted convertible notes as part of previously disclosed transactions. These securities are not intended to be quoted on the Australian Securities Exchange. Investors may find this development indicative of the company’s strategic financial maneuvers.
For further insights into AU:ZLD stock, check out TipRanks’ Stock Analysis page.
